Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. 2004

Charlotte Atkinson, and Ruth M L Warren, and Evis Sala, and Mitch Dowsett, and Alison M Dunning, and Catherine S Healey, and Shirley Runswick, and Nicholas E Day, and Sheila A Bingham
MRC Dunn Human Nutrition Unit, Cambridge, UK.

BACKGROUND Isoflavones are hypothesized to protect against breast cancer, but it is not clear whether they act as oestrogens or anti-oestrogens in breast tissue. Our aim was to determine the effects of taking a red clover-derived isoflavone supplement daily for 1 year on mammographic breast density. Effects on oestradiol, follicle-stimulating hormone (FSH), luteinizing hormone (LH), lymphocyte tyrosine kinase activity and menopausal symptoms were also assessed. METHODS A total of 205 women (age range 49-65 years) with Wolfe P2 or DY mammographic breast patterns were randomly assigned to receive either a red clover-derived isoflavone tablet (26 mg biochanin A, 16 mg formononetin, 1 mg genistein and 0.5 mg daidzein) or placebo. Change in mammographic breast density, serum oestradiol, FSH, LH, menopausal symptoms and lymphocyte tyrosine kinase activity from baseline to 12 months were assessed. RESULTS A total of 177 women completed the trial. Mammographic breast density decreased in both groups but the difference between the treatment and placebo was not statistically significant. There was a significant interaction between treatment group and oestrogen receptor (ESR1) PvuII polymorphism for the change in estimated percentage breast density (mean +/- standard deviation): TT isoflavone 1.4 +/- 12.3% and TT placebo -9.6 +/- 14.2%; CT isoflavone -5.2 +/- 12.0% and CT placebo -2.8 +/- 10.3%; and CC isoflavone -3.4 +/- 9.7% and CC placebo -1.1 +/- 9.5%. There were no statistically significant treatment effects on oestradiol, FSH, or LH (assessed only in postmenopausal women), or on lymphocyte tyrosine kinase activity. Baseline levels of menopausal symptoms were low, and there were no statistically significant treatment effects on frequency of hot flushes or other menopausal symptoms. CONCLUSIONS In contrast to studies showing that conventional hormone replacement therapies increase mammographic breast density, the isoflavone supplement did not increase mammographic breast density in this population of women. Furthermore, there were no effects on oestradiol, gonadotrophins, lymphocyte tyrosine kinase activity, or menopausal symptoms.

UI MeSH Term Description Entries
D007529 Isoflavones 3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. 3-Benzylchroman-4-One,3-Benzylidene-4-Chromanone,Homoisoflavone,Homoisoflavones,Isoflavone,Isoflavone Derivative,3-Benzylchroman-4-Ones,3-Benzylidene-4-Chromanones,Isoflavone Derivatives,3 Benzylchroman 4 One,3 Benzylchroman 4 Ones,3 Benzylidene 4 Chromanone,3 Benzylidene 4 Chromanones,Derivative, Isoflavone,Derivatives, Isoflavone
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008327 Mammography Radiographic examination of the breast. 3D-Mammography,Digital Breast Tomosynthesis,Digital Mammography,X-ray Breast Tomosynthesis,3D Mammography,3D-Mammographies,Breast Tomosyntheses, Digital,Breast Tomosyntheses, X-ray,Breast Tomosynthesis, Digital,Breast Tomosynthesis, X-ray,Digital Breast Tomosyntheses,Digital Mammographies,Mammographies,Mammographies, Digital,Mammography, Digital,X ray Breast Tomosynthesis,X-ray Breast Tomosyntheses
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D001940 Breast In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES. Breasts
D003238 Connective Tissue Tissue that supports and binds other tissues. It consists of CONNECTIVE TISSUE CELLS embedded in a large amount of EXTRACELLULAR MATRIX. Connective Tissues,Tissue, Connective,Tissues, Connective

Related Publications

Charlotte Atkinson, and Ruth M L Warren, and Evis Sala, and Mitch Dowsett, and Alison M Dunning, and Catherine S Healey, and Shirley Runswick, and Nicholas E Day, and Sheila A Bingham
October 2013, Menopause (New York, N.Y.),
Charlotte Atkinson, and Ruth M L Warren, and Evis Sala, and Mitch Dowsett, and Alison M Dunning, and Catherine S Healey, and Shirley Runswick, and Nicholas E Day, and Sheila A Bingham
January 2015, European journal of clinical nutrition,
Charlotte Atkinson, and Ruth M L Warren, and Evis Sala, and Mitch Dowsett, and Alison M Dunning, and Catherine S Healey, and Shirley Runswick, and Nicholas E Day, and Sheila A Bingham
February 2004, The American journal of clinical nutrition,
Charlotte Atkinson, and Ruth M L Warren, and Evis Sala, and Mitch Dowsett, and Alison M Dunning, and Catherine S Healey, and Shirley Runswick, and Nicholas E Day, and Sheila A Bingham
April 2021, Journal of food science,
Charlotte Atkinson, and Ruth M L Warren, and Evis Sala, and Mitch Dowsett, and Alison M Dunning, and Catherine S Healey, and Shirley Runswick, and Nicholas E Day, and Sheila A Bingham
November 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
Charlotte Atkinson, and Ruth M L Warren, and Evis Sala, and Mitch Dowsett, and Alison M Dunning, and Catherine S Healey, and Shirley Runswick, and Nicholas E Day, and Sheila A Bingham
September 2023, Nutrients,
Charlotte Atkinson, and Ruth M L Warren, and Evis Sala, and Mitch Dowsett, and Alison M Dunning, and Catherine S Healey, and Shirley Runswick, and Nicholas E Day, and Sheila A Bingham
January 2001, Menopause (New York, N.Y.),
Charlotte Atkinson, and Ruth M L Warren, and Evis Sala, and Mitch Dowsett, and Alison M Dunning, and Catherine S Healey, and Shirley Runswick, and Nicholas E Day, and Sheila A Bingham
October 2008, Journal of women's health (2002),
Charlotte Atkinson, and Ruth M L Warren, and Evis Sala, and Mitch Dowsett, and Alison M Dunning, and Catherine S Healey, and Shirley Runswick, and Nicholas E Day, and Sheila A Bingham
May 1996, Obesity research,
Charlotte Atkinson, and Ruth M L Warren, and Evis Sala, and Mitch Dowsett, and Alison M Dunning, and Catherine S Healey, and Shirley Runswick, and Nicholas E Day, and Sheila A Bingham
August 2015, European heart journal,
Copied contents to your clipboard!